Instead of providing detailed reports of the tests
Post# of 148171
(Total Views: 426)
Posted On: 03/07/2021 9:27:49 AM
Re: ClosetInvestor #81511
Quote:
Instead of providing detailed reports of the tests establishing the safety of a new drug and substantial evidence of clinical effectiveness as required by the Food and Drug Regulations, the Interim Order requires an applicant to submit the known information with respect to the safety and effectiveness of a COVID-19 drug.
This should be a slam-dunk for Leronlimab!
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼